Back to Evidence
Primary experimental recordPositive observation

PMC12024264::ACT015981

RV-23

Evidence text

Paper-level observation

According to the best antimicrobial activity evidenced for RV-23, its combination with meropenem provides the best results, with a MIC at ... 6.25 μM (peptide) and 2.5 μg/mL (antibiotic) against E. coli.
textConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antibacterial
Measure
MIC
Comparator
=
Raw observation
6.25 μM (peptide) and 2.5 μg/mL (antibiotic)
Normalized measurement
=6.25 µM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Escherichia coli
Assay method
Not reported by source
Sequence
RIGVLLARLPKLFSLFKLMGKKV
Standardization
ready simple

Source publication

Frog Skin Peptides Hylin-a1, AR-23, and RV-23: Promising Tools Against Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae Infections

Antibiotics · 2025

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.